Opinion
Samsung, the hedge fund and the law
Legal pressures on South Korea's biggest company could help bring corporate reform
Biotechnology
Companies
Samsung offices raided in BioLogics accounting probe
Prosecutors to weigh questioning senior executives at electronics maker
Companies
India's Lupin targets generic potential of biotech drugs
Expiring patents open window for launch in Japan and Europe by year end
Markets
Samsung Biologics under scrutiny again over 2016 IPO
Korea Exchange suspected of loosening regulations to help listing
Startups
Biotech startup turns palm waste into high-value chemicals
Japan's GEI sees a market in making plantations more profitable and sustainable
Companies
Court suspends disciplinary action against Samsung BioLogics
Regulator's order to dismiss CEO on hold until conclusion of main lawsuit
Companies
S Korean pharma laid low by global retreat and Samsung scandal
Scandal compounds grim mood as international partnerships flop
Startups
Japanese spider-thread startup nets $44m for new Thai plant
Spiber hopes eco-friendly synthetic will satisfy '15% to 20%' of overall fiber demand
Technology
The businesses behind the doctor who manipulated baby DNA
He Jiankui's Direct Genomics built on failure of adviser's US company
Companies
Samsung BioLogics trading suspended after fraud ruling
South Korean financial regulator orders delisting review
